References
- Mullighan CG. Molecular genetics of B-precursor acute lymphoblastic leukemia. J Clin Invest. 2012;122(10):3407–3415. doi:10.1172/JCI61203.
- Conter V, Bartram CR, Valsecchi MG, Eriksson N, Crawford DC, Lee M-TM, Chen C-H, Motsinger-Reif A, Sagreiya H, Liu N, et al. Molecular response to treatment redefines all prognostic factors in children and adolescents with B-cell precursor acute lymphoblastic leukemia: results in 3184 patients of the AIEOP-BFM ALL 2000 study. Blood. 2010;115(16):3206–3214. doi:10.1182/blood2009-10-248146.
- Prucker C, Attarbaschi A, Peters C, Dworzak MN, Po U. Induction death and treatment-related mortality in first remission of children with acute lymphoblastic leukemia: a population-based analysis of the Austrian Berlin-Frankfurt-Münster study group. Leukemia. 2009 Jul;23(7):1264–9. doi:10.1038/leu.2009.12.
- Anderson K, Lutz C, Van Delft FW, Bateman CM, Guo Y, Colman SM, Kempski H, Moorman AV, Titley I, Swansbury J, et al. Genetic variegation of clonal architecture and propagating cells in leukaemia. Nature. 2011;469(7330):356–361. doi:10.1038/nature09650.
- Longo DL, Hunger SP, Mullighan CG. Acute lymphoblastic leukemia in children. N Engl J Med. 2015;373(16):1541–1552. doi:10.1056/NEJMra1400972.
- Good Z, Sarno J, Jager A, Samusik N, Aghaeepour N, Simonds EF, White L, Lacayo NJ, Fantl WJ, Fazio G, et al. Single-cell developmental classification of B cell precursor acute lymphoblastic leukemia at diagnosis reveals predictors of relapse. Nat Med. 2018;24(January):474–483. doi:10.1038/nm.4505.
- Bendall SC, Davis KL, Amir EAD, et al. Single-cell trajectory detection uncovers progression and regulatory coordination in human b cell development. Cell. 2014;157(3):714–725. doi:10.1016/j.cell.2014.04.005.
- Müschen M. Autoimmunity checkpoints as therapeutic targets in B cell malignancies. Nat Rev Cancer. 2018;18(2):103–116. doi:10.1038/nrc.2017.111.